Pain Patch Market to Reach $ 7.3 Billion, Globally, by 2031 | 4.3% CAGR

The global pain patch industry generated $4.8 billion in 2021 and is anticipated to generate $7.3 billion by 2031, witnessing a CAGR of 4.3% from 2022 to 2031.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲- https://www.alliedmarketresearch.com/request-sample/13041

𝐏𝐫𝐢𝐦𝐞 𝐝𝐞𝐭𝐞𝐫𝐦𝐢𝐧𝐚𝐧𝐭𝐬 𝐨𝐟 𝐠𝐫𝐨𝐰𝐭𝐡

Rise in the prevalence of chronic pain such as back pain, arthritis and other chronic pain causing diseases, technological advancement in pain patches and rising adoption of pain patch for pain management, drive the growth of the global pain patch market. However, stringent regulatory guidelines for product approval and the availability of alternate treatments are hampering the pain patch market growth. On the contrary, the growth opportunities in emerging markets are expected to offer remunerative opportunities for the expansion of the pain patch market during the forecast period.

𝐈𝐦𝐩𝐚𝐜𝐭 𝐨𝐟 𝐂𝐨𝐯𝐢𝐝-𝟏𝟗 𝐨𝐧 𝐭𝐡𝐞 𝐏𝐚𝐢𝐧 𝐏𝐚𝐭𝐜𝐡 𝐌𝐚𝐫𝐤𝐞𝐭-

The pandemic created several challenges for the pain patch, such as disruptions in supply chains, and increased demand for COVID-19 testing.
However, rise in prevalence of chronic pain disorders such as neuropathic pain, musculoskeletal pain and joint pain was observed resulting in demand of appropriate pain management solutions is expected to contribute to the growth of the market in the forecast period.

𝐏𝐫𝐨𝐜𝐮𝐫𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 (𝟑𝟕𝟒 𝐏𝐚𝐠𝐞𝐬 𝐏𝐃𝐅 𝐰𝐢𝐭𝐡 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬, 𝐂𝐡𝐚𝐫𝐭𝐬, 𝐓𝐚𝐛𝐥𝐞𝐬, 𝐚𝐧𝐝 𝐅𝐢𝐠𝐮𝐫𝐞𝐬)
https://www.alliedmarketresearch.com/checkout-final/pain-patch-market

𝐓𝐡𝐞 𝐧𝐨𝐧-𝐨𝐩𝐢𝐨𝐢𝐝𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩 𝐬𝐭𝐚𝐭𝐮𝐬 𝐭𝐡𝐫𝐨𝐮𝐠𝐡𝐨𝐮𝐭 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝

Based on product type, the non-opioids segment held the largest share in 2021, accounting for more than half of the global pain patch revenue, and is estimated to maintain its leadership status throughout the forecast period. Moreover, the same segment is projected to manifest the highest CAGR of 4.7% during the forecast period. 

𝐓𝐡𝐞 𝐩𝐫𝐞𝐬𝐜𝐫𝐢𝐩𝐭𝐢𝐨𝐧 𝐦𝐞𝐝𝐢𝐜𝐢𝐧𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝

Based on type, the prescription medicines segment accounted for the largest share in 2021, accounting for more than 90% of the global pain patch revenue, owing to advantages as they provide correct number of drugs in the treatment of pain without causing much side effects, and commonly the opioids patches and NSAIDS are prescribed which are proven to be effective in chronic pain management.  However, the OTC Medicines segment is projected to manifest the highest CAGR of 5.4% from 2022 to 2031, owing to rise in demand of personalization of pain management and availability of some pain patches without a prescription.

𝐓𝐡𝐞 𝐝𝐫𝐮𝐠 𝐬𝐭𝐨𝐫𝐞𝐬 𝐚𝐧𝐝 𝐫𝐞𝐭𝐚𝐢𝐥 𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐢𝐞𝐬 𝐬𝐞𝐠𝐦𝐞𝐧𝐭 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐥𝐞𝐚𝐝 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧 𝐝𝐮𝐫𝐢𝐧𝐠 𝐭𝐡𝐞 𝐟𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝐩𝐞𝐫𝐢𝐨𝐝

Based on distribution channel, the drug stores and retail pharmacies segment accounted for the largest share in 2021, accounting for more than half of the global pain patch revenue, owing to increase in preference of the people toward retail pharmacies, as retail pharmacies guide regarding medications and usage during treatment period. However, the online Providers segment is projected to manifest the highest CAGR of 7.7% from 2022 to 2031, owing to rise in popularity of online pharmacy and number of users preferring online providers.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲- https://www.alliedmarketresearch.com/purchase-enquiry/13041

𝐍𝐨𝐫𝐭𝐡 𝐀𝐦𝐞𝐫𝐢𝐜𝐚 𝐭𝐨 𝐦𝐚𝐢𝐧𝐭𝐚𝐢𝐧 𝐢𝐭𝐬 𝐝𝐨𝐦𝐢𝐧𝐚𝐧𝐜𝐞 𝐛𝐲 𝟐𝟎𝟑𝟏

Based on region, North America held the highest market share in terms of revenue in 2021, accounting for around two- fifth of the global pain patch revenue, owing to owing to rise in prevalence of chronic pain cases, presence of key players offering pain patches, ease of availability, higher awareness regarding pain patch, and developed healthcare infrastructure drive the growth of the pain patch market. However, the Asia-Pacific region is expected to witness the fastest CAGR of 5.3% from 2022 to 2031, and is likely to dominate the market during the forecast period, owing increase in investments for development of novel drug delivery system, surge in geriatric population and rise in awareness of advanced method for pain management thereby driving the growth of the market during the forecast period. 

𝐋𝐞𝐚𝐝𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐥𝐚𝐲𝐞𝐫𝐬: -

Viatris Inc.
Johnson & Johnson
Teva Pharmaceutical Industries Ltd.
Hisamitsu Pharmaceutical Co. Inc.
Endo International PLC.
Nexgel Advanced Hydrogel Solutions
Purdue Pharma L.P.
Sorrento Therapeutics Inc.
Amneal Pharmaceuticals LLC
Grunenthal

The report provides a detailed analysis of these key players of the global pain patch market. These players have adopted different strategies such as expansion, product launch, development and product approval, to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
help@alliedmarketresearch.com

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned.

This release was published on openPR.